The statins may induce mitochondria phenotypic changes through direct inhibition of muscular Hmgcr and myofibrillar damage reminiscent of myopathy that is associated with inhibition of skeletal muscle ClC-a. The gene discussed is HMGCR; the disease is myopathy.